Emory University, USA
Periasamy Selvaraj received his Masters degree in Biochemistry from University of Madras, Chennai, India and his Ph.D. from Christian Medical College, Vellore, India. He did his postdoctoral fellowship in cell adhesion receptors of the immune system at Dana Farber Cancer Institute, Harvard Medical School, Boston under the supervision of Dr. Timothy A. Springer. Currently, he is a Professor in the Department of Pathology at Emory University School of Medicine, Atlanta, GA, USA. His laboratory focuses on developing cancer vaccines using novel protein transfer approaches, which could be used as an alternative to gene transfer based cancer vaccines in human clinical settings. He is also co-founder of Metaclipse Therapeutics Corporation, which is in developing personalized immunotherapy for cancers. He has published more than 80 research papers in national and international journals.